A Double-Blind, Placebo-Controlled, Randomized, Parallel Group Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Opioid Analgesia Using the Oral Surgery Model of Acute Pain in Healthy Volunteers
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
Price : $35 *
At a glance
- Drugs Rotigotine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 06 Aug 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2017 as per ClinicalTrials.gov record.
- 06 Aug 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Nov 2016 as per ClinicalTrials.gov record.
- 06 Aug 2015 Planned initiation date changed from 1 Nov 2014 to 1 Nov 2015 as per ClinicalTrials.gov record.